亚洲欧美不卡高清在线观看,伊人久久大香线蕉午夜av,亚洲综合色区在线观看,中文在线中文a,真正免费的毛片

  • Selexis, Pandion Enter Antibody Service Agreement contractpharma
    March 17, 2021
    Selexis SA, a JSR Life Sciences company, has signed a service agreement with Pandion Therapeutics, Inc. to advance the development of Pandion’s PT627, a systemically-acting PD-1 agonist antibody for the potential treatment of autoimmune and ...
  • Merck signs agreement to buy Pandion Therapeutics for $1.85bn pharmaceutical-technology
    March 01, 2021
    Merck has agreed to acquire biotechnology company Pandion Therapeutics for approximately $1.85bn to expand its portfolio of autoimmune disease-targeting candidates.
PharmaSources Customer Service